Clinuvel Europe Limited

Porphyria and Photoprotection

Clinuvel Europe Limited focuses on clinical research in erythropoietic protoporphyria (EPP), with attention to the use of afamelanotide in patients across adolescent and adult age groups. This area reflects interest in conditions linked to light sensitivity and the biological response to ultraviolet radiation.

  • Erythropoietic protoporphyria (EPP)
  • Afamelanotide
  • Photoprotection
  • Ultraviolet radiation

The sponsor also supports research examining skin DNA damage and DNA repair capacity in healthy volunteers, extending its therapeutic interest into human skin biology and light-induced cellular injury.

Neurology and Movement Disorders

The sponsor funds studies in Parkinson’s disease, with a particular focus on early Parkinson’s disease and the safety and clinical effects of afamelanotide in this neurological setting. This places neurodegenerative disease among its key therapeutic interests.

  • Parkinson’s disease
  • Early Parkinson’s disease
  • Neurodegenerative disease
  • Afamelanotide

Research activity in this domain includes clinical assessment of treatment tolerability in people with early-stage disease, indicating an interest in neurological applications beyond dermatological indications.

Stroke and Acute Neurological Injury

Clinuvel Europe Limited is active in arterial ischaemic stroke (AIS) research, with studies addressing the use of afamelanotide in the context of acute stroke. This area links the sponsor to clinical investigation in urgent cerebrovascular disease.

  • Arterial ischaemic stroke (AIS)
  • Acute stroke
  • Cerebrovascular disease
  • Afamelanotide

The sponsor’s trial portfolio includes evaluation of treatment safety in the acute neurological setting, broadening its medical interest into vascular and brain-injury related care.

Human Skin Biology and Experimental Photomedicine

Another research area centers on healthy volunteers and the study of UVR-induced DNA damage in human skin. These trials reflect interest in the biological effects of light exposure and cellular response mechanisms relevant to photomedicine.

  • Healthy volunteers
  • Human skin
  • UVR-induced DNA damage
  • DNA repair

This work connects the sponsor’s clinical portfolio with mechanistic research into cutaneous responses to radiation and the protection of skin tissue from environmental stress.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Afamelanotide on UV Radiation-Induced DNA Damage and Repair in Healthy Volunteers

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Germany
  • Safety Study of Afamelanotide for Patients with Early Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study of Afamelanotide for Patients with Erythropoietic Protoporphyria (EPP)

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Belgium The Netherlands
  • Study on the Safety and Effects of Afamelanotide for Patients with Early Parkinson’s Disease

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on the Safety of Afamelanotide for Patients with Acute Arterial Ischemic Stroke Ineligible for Standard Stroke Treatments

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain